ESR1 and neoplasm: The estrogen receptor–positive tumor demonstrated modest [18F]FGln uptake, reflecting a relatively large glutamine pool, and moderate [18F]FDG uptake, consistent with the expected biology, given this molecular phenotype (7,21).